Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study

Mitchell, Paul; Arnold, Jennifer; Fraser‐Bell, Samantha; Kwon Kang, Hyong; Chang, Andrew; Tainton, Jodi; Simonyi, Susan

doi:10.1136/bmjophth-2022-001224

Public

Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study

Published in BMJ Open Ophthalmology • Aug 1, 2023

Authors:

Paul Mitchell

Jennifer Arnold

Samantha Fraser‐Bell

Abstract

AIM: To evaluate effectiveness of dexamethasone intravitreal implant 0.7 mg (DEX) monotherapy in the AUSSIEDEX study non-responder subgroup, defined by diabetic macular oedema (DME) refractory to anti-vascular endothelial growth factor (anti-VEGF) agents. METHODS: This prospective, open-label, obser...

Subject

Medicine

Dexamethasone

Refractory (planetary science)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!